Neocytolysis: Physiological down-regulator of red-cell mass

Lancet

Volumn 349, Issue 9062, 1997, Pages 1389-1390

  Alfrey, Clarence P ^a   Rice, Lawrence ^a   Udden, Mark M ^a   Driscoll, Theda B ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN;

ANEMIA; BLOOD DISEASE; CELL AGING; COSMONAUT; ERYTHROCYTE; ERYTHROPOIESIS; HUMAN; HUMAN CELL; KIDNEY DISEASE; MEDICAL RESEARCH; MICROGRAVITY; NEOCYTOLYSIS; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0030938226     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)09208-2     Document Type: Note

References (18)

1. Koury MJ, Bondurant MC. Review: The molecular mechanism of erythropoietin action. Eur J Biochem 1992; 210: 649-63.
2. Udden MM, Driscoll TB, Pickett MH, Leach-Huntoon CS, Alfrey CP. Decreased production of red blood cells in human subjects exposed to microgravity. J Lab Clin Med 1995; 125: 442-49.
3. Alfrey CP, Udden MM, Huntoon CL, Driscoll T, Pickett MH. Control of the red blood cell mass in spaceflight. J Appl Physiol 1996; 81: 98-104.
4. Fischer CL, Johnson PC, Berry CA. Red blood cell mass and plasma volume changes in manned space flight. JAMA 1967; 200: 579-83.
5. Huff RL, Lawrence JH, Siri WE, Wasserman LR, Hennessy TG. Effects of changes in altitude on hematopoietic activity. Medicine 1951; 30: 197-217.
6. Merino CF. Studies of blood formation and destruction in the polycythemia of high altitude. Blood 1950; 5: 1-31.
7. Pace N, Meyer LB, Vaughan BE. Erythrolysis on return of altitude acclimatized individuals to sea level. J Appl Physiol 1956; 9: 141-44.
8. Fryers GR, Berlin NI. Mean red cell life of rats exposed to reduced barometric pressure. Am J Physiol 1952; 171: 465-70.
9. Crosby WH. Splenic remodelling of red cell surfaces. Blood. 1977; 50: 643-45.
10. Wilson JG, Tavassoli M. Microenvironmental factors involved in the establishment of erythropoiesis in the bone marrow. Ann N Y Acad Sci 1994; 78: 271-84.
11. Wick TM, Moake JL, Udden MMU, McIntire LV. Unusually large von Willebrand factor multimers preferentially promote young sickle and non-sickle erythrocyte adhesion to endothelial cells. Am J Hematol 1993; 42: 284-92.
12. Test ST, Hua M Styles L. Decreased expression of integrin a,b, and CD36 on circulating sickle reticulocytes and nucleated red cells following therapy with high dose erythropoietin. Blood. (suppl) 1994; 15: 1601 (abstr).
13. Berglund B, Girgegard G, Wide L, Philstedt P. Effects of blood transfusions on some haematological variables in endurance athletes. Med Sci Sports Exerc 1989; 21: 637-42.
14. Adamson JW, Eschbach J, Finch CA. The kidney and erythropoiesis. Blood 1968; 44: 725-33.
15. Eschbach JW. The anemia of chronic renal failure: pathophysiology and the effects of recombinant erythropoietin. Kidney Int 1989; 35: 134-48.
16. Granolleras C, Branger B, Shaldon S, et al. Subcutaneous erythropoietin: a comparison of daily and thrice weekly administration. Contrib Nephrol 1991; 88: 144-48.
17. Stevens ME, Summerfield GP, Hall AA, et al. Cost benefits of low dose subcutaneous erythropoietin in patients with anaemia of end stage renal disease. BMJ 1992; 304: 4741-77.
18. Mentzer WC, Baehner RL, Schmidt-Schonbein H, Robinson SH, Nathan DG. Selective reticulocyte destruction in erythrocyte pyruvate kinase deficiency. J Clin Invest 1971; 50: 688-99.